AKT1 and lung carcinoma: According to an in vitro study, a lower dose of eugenolinhibited metastasis and lung cancer cell sustainability onhuman embryonic lung fibroblast MRC-5 and lung cancer adenocarcinoma cells A549A.This was accomplished through inhibition of the PI3K/Akt pathway and prevention of MMP (matrix metalloproteinase) action.